Advertisements


Xoma"s gevokizumab used to dose first patient in cancer study by Novartis

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 13th, 2019

The Daily Biotech Pulse: Ardelyx Awaits Ruling On Constipation Drug, Double Dose Of Good News For Roche, Tocagen Flunks Brain Cancer Study

The following is a roundup of top developments in the biotech space over the last 24 hours.  Scaling The Peaks (Biotech stocks that hit 52-week highs Sept. 11.) read more.....»»

Category: blogSource: benzingaSep 12th, 2019

Vaccinex Reports Second Quarter 2019 Financial Results and Provides Corporate Update

Completed enrollment of the dose expansion cohort in the Phase 1b/2 CLASSICAL-Lung study in non-small cell lung cancer; primary completion expected in the second half of 2019 Presented interim data from CLASSICAL-Lung study.....»»

Category: earningsSource: benzingaAug 14th, 2019

Gritstone expects to dose first patient in Phase 1 SLATE-001 study mid-year

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallAug 12th, 2019

Many breast cancer patients can skip chemo, big study finds

Most women with the most common form of early-stage breast cancer can safely skip chemotherapy without hurting their chances of beating the disease, doctors are reporting from a landmark study that used genetic testing to gauge each patient's risk......»»

Category: topSource: foxnewsJun 3rd, 2018

Inovio (INO) Initiates Phase I Study on Hepatitis C Vaccine

Inovio Pharmaceuticals (INO) and Korean partner GeneOne Life Science dose the first patient in a phase I study, which will assess its hepatitis C vaccine GLS-6150. Inovio Pharmaceuticals, Inc. IN.....»»

Category: dealsSource: nytSep 4th, 2018

The Daily Biotech Pulse: BioMarin Trims Outlook, MediciNova Enrolls First Patient In Brian Cancer Drug Study

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peak (Biotech Stocks Hitting 52-week highs on Jan. 8) read more.....»»

Category: blogSource: benzingaJan 9th, 2019

Cancer worries halt shipments of generic Zantac

A division of Novartis is reportedly halting distribution of generic Zantac pills amid concerns about an ingredient p.....»»

Category: topSource: usatodaySep 19th, 2019

Biotech is going to the dogs - and big profits await

For Jessica Lescault there is no question that her 6-year old English bulldog "Moose" deserves cutting-edge biotechnology cancer treatment as much as any human patient......»»

Category: topSource: reutersSep 19th, 2019

Xynomic Pharmaceuticals doses first patient in phase 3 kidney cancer trial

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallSep 13th, 2019

Mid-Day Market Update: Tocagen Falls On Failed Late-Stage Brain Cancer Study; Sintx Technologies Shares Jump

Midway through trading Thursday, the Do.....»»

Category: earningsSource: benzingaSep 12th, 2019

Mid-Day Market Update: Tocagen Falls On Failed Late-Stage Brain Cancer Study; Sintx Technologies Shares Jump

Midway through trading Thursday, the Dow traded up 0.42% to 27,251.73 while the NASDAQ rose 0.41% to 8,203.22. The S&P also rose, gaining 0.40% to 3,012.91. Leading and Lagging Sectors read more.....»»

Category: blogSource: benzingaSep 12th, 2019

Cancer patients are turning to crowdfunding for care — and funerals

UCSF study finds that patients are shouldering the burden of higher cancer care costs......»»

Category: topSource: bizjournalsSep 9th, 2019

Amgen’s Lung Cancer Study Needs to Take a Breather

Amgen shares dropped on Monday after the firm released additional data from its early-stage lung cancer study. Specifically this data is coming from the ongoing Phase 1 study evaluating AMG 510 in........»»

Category: blogSource: 247wallstSep 9th, 2019

Surprising Reaction to Lung Cancer Study Results

Eli Lilly shares dipped on Monday after the firm announced results from its midstage clinical trial for the treatment of lung cancer......»»

Category: blogSource: 247wallstSep 9th, 2019

Amgen"s KRAS Inhibitor Shows Lukewarm Response In Lung Cancer Study

Amgen, Inc. (NASDAQ: AMGN) shares were pulling back Monday following the presentation of new data on its investigational compound for solid tumors. read more.....»»

Category: blogSource: benzingaSep 9th, 2019

International Association for the Study of Lung Cancer to hold a conference

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: worldSource: nytSep 9th, 2019

Cyclacel Pharmaceuticals treats first patient with oral CYC065 in Phase 1 study

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallSep 9th, 2019

Novartis joins Pfizer with FDA fast-track tag for lung cancer hopeful

Novartis has nabbed the U.S. Food and Drug Administration's breakthrough therapy designation for its experimental medicine capmatinib as it joins Pfizer in the race to treat a tough-to-treat mutated lung cancer type......»»

Category: topSource: moneycentralSep 6th, 2019

Neon Therapeutics announces publication of study on cancer neoantigens

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallSep 5th, 2019

Denali Therapeutics doses first patient in Phase 1b study of DNL151

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallSep 4th, 2019